Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.24 USD | +0.74% | -5.44% | -26.87% |
08/05 | Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.87% | 568M | |
+28.88% | 49.18B | |
+0.86% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.18% | 18.71B | |
+7.85% | 13.26B | |
+32.41% | 12.32B | |
-0.63% | 11.99B |
- Stock Market
- Equities
- OLMA Stock
- News Olema Pharmaceuticals, Inc.
- Credit Suisse Lowers Olema Pharmaceuticals' Price Target to $11 From $12, Keeps Outperform Rating